Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

OncoSil Pancreatic Cancer Post-marketing Clinical Registry Italy

NCT06399172 is registered in ClinicalTrials.gov with OncoSil Medical Limited as lead sponsor.

NCT NCT06399172
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06399172 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
OncoSil Pancreatic Cancer Post-marketing Clinical Registry Italy
Lead sponsor
OncoSil Medical Limited
Phase
Observational
Overall status
Not yet recruiting
Start date
May 30, 2024
Completion date
October 30, 2029
Enrollment
50 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

locally advanced pancreatic adenocarcinoma